BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 14533700)

  • 1. Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
    Goswick SM; Brenner GM
    J Parasitol; 2003 Aug; 89(4):837-42. PubMed ID: 14533700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
    Soltow SM; Brenner GM
    Antimicrob Agents Chemother; 2007 Jan; 51(1):23-7. PubMed ID: 17060522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of rokitamycin in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
    Kim JH; Lee YJ; Sohn HJ; Song KJ; Kwon D; Kwon MH; Im KI; Shin HJ
    Int J Antimicrob Agents; 2008 Nov; 32(5):411-7. PubMed ID: 18762406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of Naegleria fowleri primary amebic meningocephalitis (PAM) could be improved with an intensive multi-route chemo- and biotherapeutic regimen.
    Alisky JM
    Med Hypotheses; 2008 Dec; 71(6):969-71. PubMed ID: 18715722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.
    Kim JH; Jung SY; Lee YJ; Song KJ; Kwon D; Kim K; Park S; Im KI; Shin HJ
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4010-6. PubMed ID: 18765686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
    Goswick SM; Brenner GM
    Antimicrob Agents Chemother; 2003 Feb; 47(2):524-8. PubMed ID: 12543653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of isoflavans of Dalea aurea (Fabaceae) against the opportunistic ameba naegleria fowleri.
    Belofsky G; Carreno R; Goswick SM; John DT
    Planta Med; 2006 Mar; 72(4):383-6. PubMed ID: 16557484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.
    Debnath A; Tunac JB; Galindo-Gómez S; Silva-Olivares A; Shibayama M; McKerrow JH
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5450-7. PubMed ID: 22869574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary amoebic meningoencephalitis due to Naegleria fowleri.
    Kaushal V; Chhina DK; Ram S; Singh G; Kaushal RK; Kumar R
    J Assoc Physicians India; 2008 Jun; 56():459-62. PubMed ID: 18822627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune response to Naegleria fowleri amebae and pathogenesis of infection.
    Marciano-Cabral F; Cabral GA
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):243-59. PubMed ID: 17894804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiparasitic Activity of Auranofin against Pathogenic Naegleria fowleri.
    Peroutka-Bigus N; Bellaire BH
    J Eukaryot Microbiol; 2019 Jul; 66(4):684-688. PubMed ID: 30520183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amebic meningoencephalitis].
    Fukuma T
    Brain Nerve; 2009 Feb; 61(2):115-21. PubMed ID: 19235460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swimming with death: Naegleria fowleri infections in recreational waters.
    Heggie TW
    Travel Med Infect Dis; 2010 Jul; 8(4):201-6. PubMed ID: 20970721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.
    Schuster FL; Guglielmo BJ; Visvesvara GS
    J Eukaryot Microbiol; 2006; 53(2):121-6. PubMed ID: 16579814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal case of Naegleria fowleri meningo-encephalitis in an infant: case report.
    Hebbar S; Bairy I; Bhaskaranand N; Upadhyaya S; Sarma MS; Shetty AK
    Ann Trop Paediatr; 2005 Sep; 25(3):223-6. PubMed ID: 16156990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cysteine protease inhibitors as new drug leads against Naegleria fowleri.
    Zyserman I; Mondal D; Sarabia F; McKerrow JH; Roush WR; Debnath A
    Exp Parasitol; 2018 May; 188():36-41. PubMed ID: 29551628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis.
    Linam WM; Ahmed M; Cope JR; Chu C; Visvesvara GS; da Silva AJ; Qvarnstrom Y; Green J
    Pediatrics; 2015 Mar; 135(3):e744-8. PubMed ID: 25667249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary amebic meningoencephalitis: a review of the clinical literature.
    Hannisch W; Hallagan LF
    Wilderness Environ Med; 1997 Nov; 8(4):211-3. PubMed ID: 11990164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organotypic slice cultures from rat brain tissue: a new approach for Naegleria fowleri CNS infection in vitro.
    Gianinazzi C; Schild M; Müller N; Leib SL; Simon F; Nuñez S; Joss P; Gottstein B
    Parasitology; 2005 Dec; 131(Pt 6):797-804. PubMed ID: 16336733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal primary meningoencephalitis caused by Naegleria fowleri.
    Shariq A; Afridi FI; Farooqi BJ; Ahmed S; Hussain A
    J Coll Physicians Surg Pak; 2014 Jul; 24(7):523-5. PubMed ID: 25052979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.